Dr. Berkeley W. Cue
Dr. Berkeley W. Cue will be giving a plenary address, "Sustainability: Will It Be Sputniks or Boiled Frogs?" at 6:30pm on Thursday, June 3rd in Kellas 106. He is also the organizer of the symposium Green chemistry in industry for a sustainable world.
Berkeley W. Cue, known as Buzz to most of us, consults with several technology companies who serve the pharmaceutical industry to create innovative solutions for pharmaceutical science and manufacturing challenges through BWC Pharm Consulting, LLC.
At Pfizer, until he retired, he was responsible for the departments (Analytical R&D, Bio Process R&D, Chemical R&D, Pharmaceutical R&D, Regulatory CMC & Quality Assurance and Pharmaceutical Sciences Business Operations) that comprise Pharmaceutical Sciences at their Groton R&D site. He was a member of the Worldwide Pharmaceutical Sciences Executive Team, sponsored the global Chemical R&D line council, and was a member of the Groton Laboratories site Leadership Team. He created and led Pfizer’s Green Chemistry initiative and has spoken extensively on this topic since 2000. Dr. Cue retired from Pfizer in April 2004 after almost 29 years, but he continues his mission of advancing green chemistry in the pharmaceutical industry. Since he retired in 2004 he has given more than one hundred presentations on green chemistry and sustainability in the pharmaceutical industry.
Buzz started in Pfizer in 1975 in the Animal Health Organic Chemistry Department. He transferred to the Process R&D Department of Developmental Research in 1979. He became head of the PR&D Department in Pfizer’s Groton CT R&D Center in 1988, assumed responsibility for Analytical and Bio Process R&D as well in 1993 and US Developmental Research in 1998. He chaired the Cardiovascular & Metabolic Diseases Early Development Management Team (1998-1999) and co-chaired the division’s Performance Management Task Force (1992-1993). He was Groton Labs executive sponsor for the Women Leaders Network (2002-2004).
He received a BA with honors from the University of Massachusetts-Boston (1969), his Ph.D. (Organic Chemistry) from the University of Alabama (1973), and completed Postdoctoral Research at the Ohio State University (1974), National Cancer Institute Research Fellow, University of Minnesota (1975). He is a member of the Gamma Sigma Epsilon chemistry honors fraternity at the University of Alabama. In 2003 he received the Pfizer Groton Labs Green Chemistry Award and in 2005 he was presented the Seldon Award by U. Mass-Lowell for his contributions to green chemistry. That year he also received an award from the Green Chemistry Institute for his leadership of Pfizer’s green chemistry efforts that have become a model for other pharmaceutical companies. In 2006 he was recognized by the US EPA for his “tireless efforts to encourage pharmaceutical companies to implement green chemistry.” Recently he was nominated to be a candidate for election to President of the American Chemical Society (2011 term), but was not elected to serve.
In 1999 he was appointed to the Science Advisory Board at the University of Massachusetts-Boston where he has lectured numerous times and also has been appointed to the Environmental Engineering Advisory Board at Suffolk University. In 2003 he was elected to the ACS Green Chemistry Institute Governing Board (and re-elected in 2006 and 2009) where he created and co-chaired the Institute’s Pharmaceutical Roundtable until 2008. On March 17, 2004 he testified before the House of Representatives Science Committee in support of the 2004 Federal Green Chemistry Act (HB 3970). In 2004, he was appointed to the National Academies of Science Committee on Grand Challenges for Sustainability in the Chemical Industry. In 2005 he was part of a National Science Foundation-sponsored joint China/US green chemistry workshop in Beijing, China, along with other select US academic and industrial green chemistry leaders. He was a member of the Board of Directors of Bend Research, Inc. in Bend, Oregon (2005-2009), and was the scientific advisor to BioVerdant in La Jolla, California (2006-2008). Also, he was a member of the Development and Commercialization Council of Neurogen Corporation in Branford, Connecticut (2004-2008). He is an advisor to and member of the Green Chemistry and Commerce Council (GC3) and the GCI/Harvard University Steering Committee on Radical Innovation for Sustainable Development. He is a member of the editorial board of Green Chemistry, Letters and Reviews. Recently he was invited to be part of an advisory board for A Coalition for a Safer & Healthier Connecticut. His professional society memberships include the American Chemical Society (ACS), the International Society of Pharmaceutical Engineering (ISPE), The American Institute of Chemical Engineers (AIChE), The American Association of Pharmaceutical Scientists (AAPS) and the New England Association of Chemistry Teachers (NEACT).
